financetom
WVVI
financetom
/
Consumer Staples
/
WVVI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Willamette Valley Vineyards, Inc.WVVI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Willamette Valley Vineyards, Inc. produces and sells wine in the United States and internationally.

It primarily offers Pinot Noir, Chardonnay, Pinot Gris, Pinot Blanc, Sauvignon Blanc, Gruner Veltliner, Rose, Brut, Brut Rose, and Riesling branded wines under the Willamette Valley Vineyards label; Semi-Sparkling Muscat branded wine under the Tualatin Estate Vineyards label; Syrah, Merlot, Cabernet Sauvignon, Grenache, Cabernet Franc, Tempranillo, Malbec, The Griffin, and Viognier branded wines under the Griffin Creek label; and Brut, Brut Rose, and Blanc de Blancs under the Domaine Willamette label.

The company also provides Pinot Noir and Chardonnay branded wine under the Elton label; Chrysologue, Merlot, and Cabernet Sauvignon branded wine under the Pambrun label; and Frontiere Syrah, Lisette Rose, Graviére Syrah, Voyageur Syrah, Bourgeois Grenache, and Voltigeur Viognier branded wine under the Maison Bleue label, as well as offers wines under the Natoma, Pere Ami, and Metis labels.

It owns and leases approximately 1,018 acres of land. The company markets and sells its wine products directly through sales at the winery; and mailing lists, as well as through distributors and wine brokers.

Willamette Valley Vineyards, Inc. was founded in 1983 and is headquartered in Turner, Oregon.

Latest News >
Futu's Wealth Business Surpasses $10 Billion in Assets Under Management
Futu's Wealth Business Surpasses $10 Billion in Assets Under Management
Jul 3, 2024
04:16 AM EDT, 07/03/2024 (MT Newswires) -- Futu Holdings ( FUTU ) said early Wednesday its wealth management business surpassed $10 billion in assets under management. The company also said its fully-owned subsidiary, Moomoo Securities Malaysia, recently received approval from the Federation of Investment Managers Malaysia to distribute wealth management products in the country. Price: 65.89, Change: -0.13, Percent Change:...
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval
Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval
Jul 3, 2024
04:15 AM EDT, 07/03/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Wednesday the European Commission has approved Dupixent as an additional maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, or COPD, a respiratory disease that damages the lungs. The decision marks the first Dupixent approval worldwide for COPD patients, the companies...
China leading generative AI patents race, UN report says
China leading generative AI patents race, UN report says
Jul 3, 2024
GENEVA, July 3 (Reuters) - China is far ahead of other countries in generative AI inventions like chatbots, filing six times more patents than its closest rival the United States, U.N. data showed on Wednesday. Generative AI, which produces text, images, computer code and even music from existing information, is exploding with more than 50,000 patent applications filed in the...
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
Jul 3, 2024
In a significant development in the battle against Alzheimer’s disease, the U.S. Food and Drug Administration (FDA) has approved Eli Lilly ( LLY ) and Company’s Alzheimer’s treatment, “Kisunla.” What Happened: As per the official press release on Tuesday, Kisunla (donanemab-azbt), a once-monthly IV infusion injection, is intended for adults in the early symptomatic stages of Alzheimer’s disease, including those...
Copyright 2023-2025 - www.financetom.com All Rights Reserved